BiotechTube
Home/Enthera Pharmaceuticals/Francesca D’addio, MD
FD

Francesca D’addio, MD

Head of Preclinical Research, Founder

Enthera Pharmaceuticals

Therapeutic Areas

Type 1 DiabetesInflammatory Bowel DiseaseAutoimmune Disorders

Enthera Pharmaceuticals Pipeline

DrugIndicationPhase
Ent001Type 1 Diabetes & Inflammatory Bowel Disease (Ulcerative Colitis)Phase 1
EbrasodebartAutoimmune Disorders (specifics not fully detailed)Preclinical or Early Clinical

Leadership Team at Enthera Pharmaceuticals

LM
Lisa Maria Olson, PhD
Chief Executive Officer
PF
Paolo Fiorina, MD
CSO, Founder
FC
Filippo Canducci, MD, PhD, MBA
Chief Medical Officer
LR
Lucia Reggi
Senior Director, Finance
View full Enthera Pharmaceuticals profile